And Lion has now received strike 3;
The Company continues to initiate and support R&D around the benefits of A1 protein-free products and develop its Intellectual Property portfolio (including brand assets and proprietary know-how)
• New studies initiated across China, USA and ANZ with a focus on human research
– Significant clinical study undertaken in China (n=600) completed and submitted for publication
– Concurrent study in China amongst pre-schoolers completed; results align with adult findings around digestive and cognitive responses
Scientific publication in October reports consumption of a2 Milk™ increases the body’s production of a key antioxidant (glutathione or GSH) in study participants relative to conventional dairy
A2 now has scientific studies showing that it has SOME effect, (assuming positive), Lion has no recent studies showing it doesn't and there are more studies coming down the line......suspect this case will go away by November.
- Forums
- ASX - By Stock
- A2M
- Ann: A2M Results Presentation Half Year FY17
Ann: A2M Results Presentation Half Year FY17, page-6
-
- There are more pages in this discussion • 320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.84 |
Change
-0.080(1.63%) |
Mkt cap ! $3.522B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.79 | $14.39M | 2.981M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 6762 | $4.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.84 | 141617 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 12075 | 4.860 |
22 | 24037 | 4.850 |
18 | 28166 | 4.840 |
10 | 33267 | 4.830 |
11 | 26450 | 4.820 |
Price($) | Vol. | No. |
---|---|---|
4.870 | 30547 | 12 |
4.880 | 35076 | 12 |
4.890 | 48342 | 12 |
4.900 | 115546 | 8 |
4.910 | 10386 | 6 |
Last trade - 12.57pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online